Extraordinarily favorable left ventricular reverse remodeling through long-term cardiac resynchronization: Super-response to cardiac resynchronization

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 7, 2012, Pages 870-876

  Çelebi, Özlem ^a   Knaus, Thomas ^a   Blaschke, Florian ^a   Habedank, Dirk ^a   Döhner, Wolfram ^a   Nitardy, Aischa ^a   Stockburger, Martin ^b,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Department of Internal Medicine/Cardiology   (Germany)

Author keywords

cardiac resynchronization; exercise testing; heart failure; high responder; left ventricular size; oxygen uptake; reverse remodeling; super responder

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ARTERY DISEASE; EXERCISE; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION TIME; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; QRS COMPLEX;

EID: 85027923420     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03417.x     Document Type: Article

References (34)

1. Xiao HB, Roy C, Fujimoto S, Gibson DG,. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996; 53: 163-170. (Pubitemid 26068420)
2. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,. for the Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. (Pubitemid 40517094)
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, et al., Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
4. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, et al., MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
5. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, et al,. Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010; 363: 2385-2395.
6. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, et al., for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003; 107: 1985-1990. (Pubitemid 36506071)
7. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, et al., MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853.
8. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, Böcker D, et al., Pacing Therapies in Congestive Heart Failure II Study Group; Guidant Heart Failure Research Group. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003; 42: 2109-2116. (Pubitemid 37549894)
9. Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, et al., MADIT-CRT Investigators. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: Cardiac resynchronization therapy. Circulation 2010; 122: 985-992.
10. Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S, Foster E, et al,. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011; 57: 2416-2423.
11. Yu CM, Bleeker GB, Fung JW, Schalij MJ, Zhang Q, van der Wall EE, Chan YS, et al,. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005; 112: 1580-1586. (Pubitemid 41324519)
12. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, et al,. American College of Cardiology/American Heart Association Task Force on Practice; American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive summary. Heart Rhythm 2008; 5: 934-955.
13. Stockburger M, Fateh-Moghadam S, Nitardy A, Langreck H, Haverkamp W, Dietz R,. Optimization of cardiac resynchronization guided by Doppler echocardiography: Haemodynamic improvement and intraindividual variability with different pacing configurations and atrioventricular delays. Europace 2006; 8: 881-886. (Pubitemid 44550619)
14. Wallerson DC, Devereux RB,. Reproducibility of echocardiographic left ventricular measurements. Hypertension 1987; 9 (Pt 2): II6-II18.
15. Anand I, Florea VG, Fisher L,. Surrogate end points in heart failure. J Am Coll Cardiol 2002; 39: 1414-1421. (Pubitemid 34439054)
16. Lee TH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, et al,. Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 1993; 72: 872-876.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, et al,. American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79-108.
18. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, Tajik AJ, et al,. New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function-A study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357-366. (Pubitemid 26011184)
19. Naughton JP, Haider R,. Methods of exercise testing. In:, Naughton JP, Hellerstein HK, Mohler IC, (eds.): Exercise Testing and Exercise Training in Coronary Artery Disease, New York, Academic Press, 1973, pp. 79-91
20. Page E, Cohen-Solal A, Jondeau G, Douard H, Roul G, Kantelip JP, Bussiere JL,: Comparison of treadmill and bicycle exercise in patients with chronic heart failure. Chest 1994; 106: 1002-1006. (Pubitemid 24309531)
21. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, Poole-Wilson PA, et al,. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure J Am Coll Cardiol 1997; 29: 1585-1590. (Pubitemid 27272454)
22. Blanc JJ, Fatemi M, Bertault V, Baraket F, Etienne Y,. Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy. Europace 2005; 7: 604-610. (Pubitemid 41488106)
23. Castellant P, Fatemi M, Bertault-Valls V, Etienne Y, Blanc JJ,. Cardiac resynchronization therapy: Nonresponders" and "hyperresponders." Heart Rhythm 2008; 5: 193-197. (Pubitemid 351168543)
24. Reant P, Zaroui A, Donal E, Mignot A, Bordachar P, Deplagne A, Solnon A, et al,. Identification and characterization of super-responders after cardiac resynchronization therapy. Am J Cardiol. 2010; 105: 1327-1335.
25. Rickard J, Kumbhani DJ, Popovic Z, Verhaert D, Manne M, Sraow D, Baranowski B, et al,. Characterization of super-response to cardiac resynchronization therapy. Heart Rhythm 2010; 7: 885-889.
26. Antõnio N, Teixeira R, Coelho L, Lourenço C, Monteiro P, Ventura M, Cristõvão J, et al,. Identification of 'super-responders' to cardiac resynchronization therapy: The importance of symptom duration and left ventricular geometry. Europace 2009; 11: 343-349.
27. van Bommel RJ, Borleffs CJ, Ypenburg C, Marsan NA, Delgado V, Bertini M, van der Wall EE, et al,. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: Influence of pre-implantation characteristics on long-term outcome. Eur Heart J 2010; 31: 2783-2790.
28. Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF,. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation 1989; 79: 845-753.
29. Stockburger M, Fateh-Moghadam S, Nitardy A, Celebi O, Krebs A, Habedank D, Dietz R,. Baseline Doppler parameters are useful predictors of chronic left ventricular reduction in size by cardiac resynchronization therapy. Europace 2008; 10: 69-74. (Pubitemid 351771253)
30. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, et al,. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117: 2608-2616.
31. Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP,. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003; 91: 684-688. (Pubitemid 36287458)
32. Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, Arnold CT, Nucifora G, et al,. Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 2011; 123: 70-78.
33. Kapetanakis S, Bhan A, Murgatroyd F, Kearney MT, Gall N, Zhang Q, Yu CM, et al,. Real-time 3D echo in patient selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging 2011; 4: 16-26.
34. Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C,. Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. Int J Cardiol 2007; 121: 68-73. (Pubitemid 47299261)